Butterfly iQ3 Ultrasound Featured in HBO Max’s The Pitt Episodes 12 and 13
Butterfly Network (NYSE: BFLY) announced that its Butterfly iQ3 ultrasound device was prominently featured in Episodes 12 and 13 of HBO Max's medical drama 'The Pitt'. The show depicts the device being used in critical trauma scenarios, particularly during a mass casualty event where traditional cart-based ultrasound equipment was replaced with Butterfly's handheld devices.
The episodes showcase the device's versatility in performing EFAST exams, blood flow evaluations, internal bleeding detection, and intracranial pressure assessments. CEO Joseph DeVivo highlighted that Butterfly devices are present in all top 100 U.S. health systems, indicating widespread adoption of the technology.
The unpaid product placement demonstrates Butterfly's growing recognition in healthcare, with the brand name becoming a verb among clinicians, according to VP of Marketing Jennifer Huang. The feature emphasizes the increasing role of Point-of-Care Ultrasound (POCUS) technology across medical specialties.
Butterfly Network (NYSE: BFLY) ha annunciato che il suo dispositivo ecografico Butterfly iQ3 è stato ampiamente presentato negli Episodi 12 e 13 del dramma medico di HBO Max 'The Pitt'. Lo show mostra l'uso del dispositivo in scenari di trauma critico, in particolare durante un evento di massa in cui l'attrezzatura ecografica tradizionale a carrello è stata sostituita dai dispositivi portatili di Butterfly.
Gli episodi mettono in evidenza la versatilità del dispositivo nell'eseguire esami EFAST, valutazioni del flusso sanguigno, rilevamento di emorragie interne e valutazioni della pressione intracranica. Il CEO Joseph DeVivo ha sottolineato che i dispositivi Butterfly sono presenti in tutti i principali 100 sistemi sanitari degli Stati Uniti, indicando un'ampia adozione della tecnologia.
Il posizionamento del prodotto non retribuito dimostra il crescente riconoscimento di Butterfly nel settore sanitario, con il nome del marchio che diventa un verbo tra i clinici, secondo la VP Marketing Jennifer Huang. Questa caratteristica sottolinea il ruolo sempre più importante della tecnologia dell'ecografia Point-of-Care (POCUS) in tutte le specialità mediche.
Butterfly Network (NYSE: BFLY) anunció que su dispositivo de ultrasonido Butterfly iQ3 fue destacado en los Episodios 12 y 13 del drama médico de HBO Max 'The Pitt'. El programa muestra el uso del dispositivo en escenarios de trauma crítico, particularmente durante un evento de múltiples víctimas donde el equipo de ultrasonido tradicional basado en carritos fue reemplazado por los dispositivos portátiles de Butterfly.
Los episodios destacan la versatilidad del dispositivo para realizar exámenes EFAST, evaluaciones del flujo sanguíneo, detección de hemorragias internas y evaluaciones de la presión intracraneal. El CEO Joseph DeVivo destacó que los dispositivos de Butterfly están presentes en los 100 principales sistemas de salud de EE. UU., lo que indica una amplia adopción de la tecnología.
La colocación de producto no remunerada demuestra el creciente reconocimiento de Butterfly en el cuidado de la salud, con el nombre de la marca convirtiéndose en un verbo entre los clínicos, según la VP de Marketing Jennifer Huang. Esta característica enfatiza el papel cada vez mayor de la tecnología de ultrasonido Point-of-Care (POCUS) en todas las especialidades médicas.
버터플라이 네트워크 (NYSE: BFLY)는 자사의 버터플라이 iQ3 초음파 기기가 HBO Max의 의료 드라마 '더 핏'의 12화와 13화에 prominently 등장했다고 발표했습니다. 이 쇼는 기기가 전통적인 카트 기반 초음파 장비 대신 버터플라이의 휴대용 장비로 대체된 대량 피해 사건에서 사용되는 모습을 보여줍니다.
이 에피소드는 EFAST 검사, 혈류 평가, 내부 출혈 감지 및 두개내 압력 평가를 수행하는 기기의 다재다능성을 보여줍니다. CEO 조셉 드비보는 버터플라이 장치가 미국의 상위 100개 건강 시스템에 모두 존재하며, 이는 기술의 광범위한 채택을 나타낸다고 강조했습니다.
비용이 없는 제품 배치는 헬스케어에서 버터플라이의 인지도가 높아지고 있음을 보여주며, 브랜드 이름이 임상의들 사이에서 동사로 사용되고 있다고 마케팅 부사장 제니퍼 황이 전했습니다. 이 기능은 모든 의료 전문 분야에서 POCUS(현장 초음파) 기술의 역할이 점점 더 중요해지고 있음을 강조합니다.
Butterfly Network (NYSE: BFLY) a annoncé que son dispositif d'échographie Butterfly iQ3 a été largement présenté dans les Épisodes 12 et 13 du drame médical de HBO Max 'The Pitt'. L'émission montre l'utilisation du dispositif dans des scénarios de traumatisme critique, en particulier lors d'un événement de masse où l'équipement d'échographie traditionnel sur chariot a été remplacé par les dispositifs portables de Butterfly.
Les épisodes mettent en avant la polyvalence du dispositif pour réaliser des examens EFAST, des évaluations du flux sanguin, la détection de saignements internes et des évaluations de la pression intracrânienne. Le PDG Joseph DeVivo a souligné que les dispositifs Butterfly sont présents dans les 100 principaux systèmes de santé des États-Unis, ce qui indique une adoption généralisée de la technologie.
Le placement de produit non rémunéré démontre la reconnaissance croissante de Butterfly dans le secteur de la santé, le nom de la marque devenant un verbe parmi les cliniciens, selon la VP Marketing Jennifer Huang. Cette caractéristique souligne le rôle croissant de la technologie d'échographie Point-of-Care (POCUS) dans toutes les spécialités médicales.
Butterfly Network (NYSE: BFLY) gab bekannt, dass ihr Butterfly iQ3 Ultraschallgerät in den Episoden 12 und 13 des HBO Max Medizin-Dramas 'The Pitt' prominent vorgestellt wurde. Die Show zeigt, wie das Gerät in kritischen Traumaszenarien eingesetzt wird, insbesondere während eines Massenschadensereignisses, bei dem traditionelle cart-basierte Ultraschallgeräte durch die tragbaren Geräte von Butterfly ersetzt wurden.
Die Episoden zeigen die Vielseitigkeit des Geräts bei der Durchführung von EFAST-Untersuchungen, Blutflussbewertungen, der Erkennung innerer Blutungen und der Beurteilung des intrakraniellen Drucks. CEO Joseph DeVivo hob hervor, dass Butterfly-Geräte in allen 100 besten Gesundheitssystemen der USA vorhanden sind, was auf eine weit verbreitete Akzeptanz der Technologie hinweist.
Die unentgeltliche Produktplatzierung zeigt die wachsende Anerkennung von Butterfly im Gesundheitswesen, wobei der Markenname laut der Marketing-VP Jennifer Huang unter Klinikern zu einem Verb geworden ist. Die Darstellung betont die zunehmende Rolle der Point-of-Care-Ultraschalltechnologie (POCUS) in allen medizinischen Fachrichtungen.
- Present in all top 100 U.S. health systems, indicating strong market penetration
- Growing brand recognition leading to 'Butterfly' becoming a verb among clinicians
- Unpaid media exposure through HBO Max series demonstrates organic market acceptance
- None.
Mainstream television use of Butterfly’s handheld ultrasound technology highlights its growing role in real-life patient care.
In the featured episodes, Butterfly Network’s handheld ultrasound devices are used extensively by the medical staff in a trauma triage setting. A pivotal episode showcases a mass casualty event in which the series lead Noah Wyle, playing the head of the ED, Dr. Michael "Robby" Robinavitch, orders the removal of traditional cart-based ultrasound equipment due to space limitations. In doing so, emphasizing the importance of mobile and efficient diagnostic tools like Butterfly. Throughout the episodes, the devices are utilized for critical assessments including EFAST exams, blood flow evaluations, and internal bleeding detection. In the latest episode, Butterfly is used to assess intracranial pressure, demonstrating its versatility in emergency and trauma care settings when used by both experienced and novice practitioners.
“This feature in The Pitt is a clear demonstration that point-of-care ultrasound is at a tipping point in healthcare,” commented Joseph DeVivo, President, Chief Executive Officer and Chairman of Butterfly Network. “What we’re seeing on screen is not just TV drama—this is happening across the country and globally. We have devices in all 100 of the top 100 U.S. health systems, and the adoption of this technology is accelerating at a pace that’s benefiting patients everywhere.”
Jennifer Huang, Butterfly Network’s Vice President of Marketing, added, “When we were asked by the production team to provide an iQ3 probe for the show, we didn’t know what to expect from an unpaid placement. The level of visibility and usage of our product in the series is a testament to the tremendous value of Butterfly’s technology and a demonstration that Butterfly is becoming the standard for handheld ultrasound. It's more than just a brand name; Butterfly is now a verb used among clinicians. It’s exciting to see how the healthcare community is increasingly recognizing its critical impact on patient care.”
The prominent placement of Butterfly iQ3 in The Pitt highlights the growing adoption of POCUS technology in real-world healthcare environments – a trend not just in trauma and emergency care but expanding across specialties. Butterfly’s portable ultrasound solutions are transforming the way medical professionals diagnose and treat patients at the point of care, empowering providers to deliver faster, more accurate assessments and improving patient outcomes.
For more information about Butterfly’s technology and its impact on healthcare, visit www.butterflynetwork.com.
About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402322282/en/
Butterfly Media:
Liz Learned
Head of Communications & PR, Butterfly
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer, Butterfly
investors@butterflynetwork.com
Source: Butterfly Network, Inc.
FAQ
How was Butterfly iQ3 (BFLY) featured in HBO Max's The Pitt medical drama?
What is the current market penetration of Butterfly Network (BFLY) in US healthcare systems?
What medical applications were demonstrated for Butterfly iQ3 (BFLY) in The Pitt series?
Was Butterfly Network (BFLY) paid for their product placement in HBO Max's The Pitt?
